Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Telemedycyna PolskaWAR:TMP +1.56%28 Gross Margin % is 90.67% as of Mar. 2026, which is 0% below its 10-year median of 90.87. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Telemedycyna Polska ranks better than 95.06% on this metric.
The historical rank and industry rank for Telemedycyna Polska's Gross Margin % or its related term are showing as below:
WAR:TMP'
s Gross Margin % Range Over the Past 10 Years
Min: 74.66 Med: 90.87 Max: 97.61
Current: 92.04
During the past 13 years, the highestGross Margin % of Telemedycyna Polska was 97.61%. The lowest was 74.66%. And the median was 90.87%.
WAR:TMP's Gross Margin % is ranked better than 95.06% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs WAR:TMP: 92.04
Telemedycyna Polska had a gross margin of 90.67% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Telemedycyna Polska was 2.80% per year.
Telemedycyna Polska (WAR:TMP) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Telemedycyna Polska had a gross margin of 90.67% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Telemedycyna Polska Gross Margin % Related Terms
Telemedycyna Polska Gross Margin % Historical Data
* Premium members only.
The historical data trend for Telemedycyna Polska's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:TMP vs VEEV, BTSG, HQY: Gross Margin % Comparison
For the Health Information Services subindustry, Telemedycyna Polska's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telemedycyna Polska Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Telemedycyna Polska's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Telemedycyna Polska (WAR:TMP) has a Gross Margin % of 90.67% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Telemedycyna Polska and its competitors. This is near median its historical median of 90.87. Over the past decade, Telemedycyna Polska's Gross Margin % has ranged from 74.66 to 97.61. According to the industry distribution chart, Telemedycyna Polska ranks #31 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 4.9%.
Is Telemedycyna Polska's Gross Margin % too high?
Telemedycyna Polska's current Gross Margin % of 90.67% is near median its 10-year median of 90.87. Over the past 10 years, this metric has ranged from a low of 74.66 to a high of 97.61. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Telemedycyna Polska's value of 90.67% is 126.3% above this industry median. Based on the distribution chart, Telemedycyna Polska ranks #31 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #31 out of 628 companies for Gross Margin %. This places Telemedycyna Polska in the top 5% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.08. Telemedycyna Polska's value of 90.67% is 126.3% above this benchmark. Historically, Telemedycyna Polska's own Gross Margin % has ranged from 74.66 to 97.61 over the past decade. While the company's 10-year median is 90.87 vs. the industry median of 40.08, Telemedycyna Polska has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telemedycyna Polska's current Gross Margin % of 90.67% is 126.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Telemedycyna Polska and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telemedycyna Polska's current Gross Margin % is 90.67%, which is near median its own 10-year median of 90.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current Gross Margin % is 90.67%, which is near median its 10-year median of 90.87 and 126.3% above the Healthcare Providers & Services industry median of 40.08. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current Gross Margin % is 90.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?
Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued.
The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82.
GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.
Key valuation signals for WAR:TMP:
Gross Margin %: 90.67% (near median its 10-year median of 90.87)
GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
Industry Position: 126.3% above the Healthcare Providers & Services median (#31 of 628)
No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score
Get the complete analysis for WAR:TMP
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:TMP has been successfully added to your 
